Meningococcal Disease Meningococcal Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-04-17
Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers. [Phase 2]
Phase 2 trial assessing immunogenicity, safety and tolerability of a bivalent recombinant lipoprotein vaccine (rLP2086) for meningococcal B …